CSI Market
Sign In | Register

Mustang Bio inc (MBIO) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access MBIO quarterly Cash Flow →
A period-by-period view of cash flow from Mustang Bio inc to Dec 31 2021 helps clarify how Dec 31 2025's cash position has changed over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income-1.92
Depreciation & amortization0.03
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation0.13
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt0.00
Issuance Of Common Stock For License Expenses-
Research And Development Asset Acquired Other Than Through Business Combination Written Off-
Issuance Of Common Shares Equity Fee On Venture Notes-
Research And Devlopment License In Accounts Payable And Accrued Expense-
Operating Lease Right Of Use Assets Amortization-
Issuance Of Common Shares Equity Fee On At Market Offering-
Issuance Of Common Shares Equity Fee On Public Offering-
Research And Development License In Accounts Payable And Accrued Expense-
Operating Lease Right Of Use Asset Amortization Expense0.01
Gain On Lease Modification-0.39
Issuance Of Common Shares Equity Fee On Equity Offering0.40
Increase Decrease In Lease Liabilities-1.97
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Other Receivables0.44
Increase (Decrease) in Due to Related Parties, Total-0.16
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets0.09
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-1.90
Discontinued operations0.00
Net Cash flow from Operating Activities-5.26
Investing Activities
Capital Expenditures0.00
Sale of Capital Items1.17
Proceeds from Maturities, Prepayments and Calls of Held-to-maturity Securities0.00
Payments to Acquire Held-to-maturity Securities0.00
Real Estate Investments0.00
Payments For Security Depsots-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Proceeds from Sale and Maturity of Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities1.17
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock7.15
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net6.17
Proceeds From Notes Payable Gross-
Stock Issued0.61
Liabilities Assumed-
Proceeds From Horizon Notes-
Proceeds From Issuance Of Common Shares At Market Offering0.60
Offering Costs For Issuance Of Common Shares At Market Offering-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities14.53
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-4.10
Total Cash Flow10.43
4 historic quarters locked

Sign in to unlock the full Mustang Bio inc cash flow history.

Sign In Create Free Account

About Mustang Bio Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001104659-26-032063

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License